Overexpression of PIK3CA and consequent Akt activation is also common among gastric malignancies [21,24,25]; thus, constituents of the PI3K/Akt pathway may serve as therapeutic targets for the treatment of gastric cancer. The gene discussed is AKT1; the disease is gastric cancer.